Novo Nordisk's pricing methods within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, pointing out the stark distinction among U.S. selling prices and those in Europe and copyright.This led Novo Nordisk to carry out further investigation into better dosages of semag